Hybrid PET/MR imaging of the heart : Feasibility and initial results

Radiology

Volumn 268, Issue 2, 2013, Pages 366-373

  Nensa, Felix ^a   Poeppe, Thorsten D ^a   Beiderwellen, Karsten ^a   Schelhorn, Juliane ^a   Mahabadi, Amir A ^b   Erbel, Raimund ^b   Heusch, Philipp ^c   Nassenstein, Kai ^a   Bockisch, Andreas ^a   Forsting, Michael ^a   Schlosser, Thomas ^a  

^a Department of Diagnostic and Interventional Radiology and Neuroradiology ^*  (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GADOLINIUM;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEASIBILITY STUDY; HEART EDEMA; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGING SYSTEM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEADY STATE; WHOLE BODY PET;

CARDIAC-GATED IMAGING TECHNIQUES; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ORGANOMETALLIC COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 84880670098     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.13130231     Document Type: Article

References (35)

1. Christensen NL, Hammer BE, Heil BG, Fetterly K. Positron emission tomography within a magnetic field using photomultiplier tubes and lightguides. Phys Med Biol 1995;40(4):691-697.
2. Pichler BJ, Wehrl HF, Kolb A, Judenhofer MS. Positron emission tomography/magnetic resonance imaging: The next generation of multimodality imaging? Semin Nucl Med 2008;38(3):199-208.
3. Torigian DA, Zaidi H, Kwee TC, et al. PET/MR imaging: Technical aspects and potential clinical applications. Radiology 2013;267(1):26-44.
4. Hartiala J, Knuuti J. Imaging of the heart by MRI and PET. Ann Med 1995;27(1):35-45.
5. Nekolla SG, Martinez-Moeller A, Saraste A. PET and MRI in cardiac imaging: From validation studies to integrated applications. Eur J Nucl Med Mol Imaging 2009;36(suppl 1):S121-S130.
6. Klein C, Nekolla SG, Bengel FM, et al. Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: Comparison with positron emission tomography. Circulation 2002;105(2):162-167.
7. Sasano T, Abraham MR, Chang KC, et al. Abnormal sympathetic innervation of viable myocardium and the substrate of ventricular tachycardia after myocardial infarction. J Am Coll Cardiol 2008;51(23):2266-2275.
8. Schlosser T, Nensa F, Mahabadi AA, Poeppel TD. Hybrid MRI/PET of the heart: A new complementary imaging technique for simultaneous acquisition of MRI and PET data. Heart 2013;99(5):351-352.
9. Ibrahim T, Nekolla SG, Langwieser N, et al. Simultaneous positron emission tomography/magnetic resonance imaging identifies sustained regional abnormalities in cardiac metabolism and function in stress-induced transient midventricular ballooning syndrome: A variant of Takotsubo cardiomyopathy. Circulation 2012;126(21):e324-e326.
10. Delso G, Fürst S, Jakoby B, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med 2011;52(12):1914-1922.
11. Martinez-Möller A, Souvatzoglou M, Delso G, et al. Tissue classification as a potential approach for attenuation correction in whole-body PET/MRI: Evaluation with PET/CT data. J Nucl Med 2009;50(4):520-526.
12. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Com-mittee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105(4):539-542.
13. Keller SH, Holm S, Hansen AE, et al. Image artifacts from MR-based attenuation correction in clinical, whole-body PET/MRI. MAGMA 2013;26(1):173-181.
14. Beyer T, Weigert M, Quick HH, et al. MRbased attenuation correction for torso-PET/MR imaging: Pitfalls in mapping MR to CT data. Eur J Nucl Med Mol Imaging 2008;35(6):1142-1146.
15. Keereman V, Fierens Y, Broux T, De Deene Y, Lonneux M, Vandenberghe S. MRI-based attenuation correction for PET/MRI using ultrashort echo time sequences. J Nucl Med 2010;51(5):812-818.
16. Delso G, Martinez-Möller A, Bundschuh RA, Nekolla SG, Ziegler SI. The effect of limited MR field of view in MR/PET attenuation correction. Med Phys 2010;37(6):2804-2812.
17. Rischpler C, Nekolla SG, Dregely I, Schwaiger M. Hybrid PET/MR imaging of the heart: Potential, initial experiences, and future prospects. J Nucl Med 2013;54(3):402-415.
18. Blumhagen JO, Ladebeck R, Fenchel M, Scheffler K. MR-based field-of-view extension in MR/PET: B0 homogenization using gradient enhancement (HUGE). Magn Reson Med http://onlinelibrary.wiley.com/doi/10.1002/mrm.24555/abstract. Published November 30, 2012. Accessed March 27, 2013.
19. Nuyts J, Bal G, Kehren F, Fenchel M, Michel C, Watson C. Completion of a truncated attenuation image from the attenuated PET emission data. IEEE Trans Med Imaging 2013;32(2):237-246.
20. Marshall HR, Prato FS, Deans L, Théberge J, Thompson RT, Stodilka RZ. Variable lung density consideration in attenuation correction of whole-body PET/MRI. J Nucl Med 2012;53(6):977-984.
21. Rahmim A, Rousset O, Zaidi H. Strategies for motion tracking and correction in PET. PET Clin 2007;2(2):251-266.
22. Le Meunier L, Slomka PJ, Dey D, et al. Motion frozen (18)F-FDG cardiac PET. J Nucl Cardiol 2011;18(2):259-266.
23. Nehmeh SA, Erdi YE. Respiratory motion in positron emission tomography/computed tomography: A review. Semin Nucl Med 2008;38(3):167-176.
24. Chun SY, Reese TG, Ouyang J, et al. MRI-based nonrigid motion correction in simultaneous PET/MRI. J Nucl Med 2012;53(8):1284-1291.
25. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100(19):1992-2002.
26. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343(20):1445-1453.
27. Hunold P, Brandt-Mainz K, Freudenberg L, et al. Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging: Comparison of the late enhancement technique with positronemission tomography [in German]. Rofo 2002;174(7):867-873.
28. Higuchi T, Nekolla SG, Jankaukas A, et al. Characterization of normal and infarcted rat myocardium using a combination of smallanimal PET and clinical MRI. J Nucl Med 2007;48(2):288-294.
29. Schinkel AF, Poldermans D, Elhendy A, Bax JJ. Assessment of myocardial viability in patients with heart failure. J Nucl Med 2007;48(7):1135-1146.
30. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008;117(1):103-114.
31. Anselm DD, Anselm AH, Renaud J, et al. Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction. J Nucl Cardiol 2011;18(4):657-667.
32. Croisille P, Kim HW, Kim RJ. Controversies in cardiovascular MR imaging: T2-weighted imaging should not be used to delineate the area at risk in ischemic myocardial injury. Radiology 2012;265(1):12-22.
33. Arai AE, Leung S, Kellman P. Controversies in cardiovascular MR imaging: Reasons why imaging myocardial T2 has clinical and pathophysiologic value in acute myocardial infarction. Radiology 2012;265(1):23-32.
34. Lee WW, Marinelli B, van der Laan AM, et al. PET/MRI of inflammation in myocardial infarction. J Am Coll Cardiol 2012;59(2):153-163.
35. Stacy MR, Maxfield MW, Sinusas AJ. Targeted molecular imaging of angiogenesis in PET and SPECT: A review. Yale J Biol Med 2012;85(1):75-86.